NCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
Clinical Trials
3 trialsNCT06948539 2025-04-29
To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
NCT06809946 2025-02-20
Feasibility of Fluorescence Imaging with Bevacizumab-800CW During Bronchoscopy
University Medical Center Groningen
Phase 1/2 Not yet recruiting